Key result
Growth hormone releasing peptides regulate PPARgamma through interaction with CD36 and GHS-R1a receptors, presenting potential therapeutic approaches for metabolic diseases.
Design
Review
Authors
Loading...
May support GHRP investigation for metabolic disease via PPARγ; leaves open clinical translation from review-level data.
Growth hormone releasing peptides may regulate PPARgamma through CD36 and ghrelin receptors, offering potential novel therapeutic approaches for metabolic diseases.
Demers et al. (2008) conducted a review in Metabolic diseases. Growth hormone releasing peptides was evaluated. Growth hormone releasing peptides regulate PPARgamma through interaction with CD36 and GHS-R1a receptors, presenting potential therapeutic approaches for metabolic diseases.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: